DiagnoCure Provides Update on Operations

Published: Apr 02, 2008

QUEBEC CITY, April 1 /CNW Telbec/ - DiagnoCure Inc. today provided an update on its Previstage(TM) GCC Colorectal Cancer Staging Test and its PCA3 test for prostate cancer. "We have recently reached some key milestones, which represent a great start for 2008 and beyond", said John Schafer, President and CEO of DiagnoCure.

Back to news